Lazard, Inc. 8-K Filing Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Lazard Ltd on September 2, 2008, regarding events occurring on September 2 and September 3, 2008. The filing details the entry into material definitive agreements concerning a secondary offering of Class A common stock by certain selling shareholders.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a securities offering.
- Shares Offered: 6,442,721 shares of Class A common stock by Selling Shareholders.
- Over-Allotment Option: Underwriters have the option to purchase up to an additional 715,858 shares.
- Lazard Group Purchase: Lazard Group LLC agreed to purchase 715,858 shares from Selling Shareholders at the public offering price less the underwriting discount, conditioned on the closing of the Offering.
- Underwriters: Goldman, Sachs & Co. and Lazard Capital Markets LLC.
Material Changes
The primary material change is the execution of an Underwriting Agreement and a Pricing Agreement to facilitate the sale of shares by existing shareholders. This transaction does not represent a primary capital raise for the Company, as the proceeds are to be received by the Selling Shareholders. The Board of Directors approved the Offering on August 28, 2008.
Outlook, Risks, and Unusual Items
Closing Date: The Offering is expected to close on September 9, 2008.
Contingencies: The purchase of shares by Lazard Group is explicitly conditioned upon the closing of the Offering.
Risks: The filing does not contain specific risk factors or management commentary regarding future business outlook, as it is a transactional report.
Investor Verification Checklist
- Verify the final closing date of the Offering (expected September 9, 2008).
- Confirm the public offering price per share, which is not stated in this summary text.
- Review the full Underwriting Agreement (Exhibit 1.1) and Pricing Agreement (Exhibit 1.2) for specific terms regarding the over-allotment option and Lazard Group Purchase.
- Identify the specific "Selling Shareholders" to understand the dilution impact on remaining shareholders.